Antimicrobial susceptibility patterns of bacteria that commonly cause bacteremia at a tertiary hospital in Zambia

Papers of special note have been highlighted as: • of interest; •• of considerable interest

References

• 1. Schellack N, Messina A. “Esprit de corps”: towards collaborative integration of pharmacists and nurses into antimicrobial stewardship programmes in South Africa. S. Afr. Med. J. 106(10), 973–974 (2016).
  Medline CASGoogle Scholar
• 2. Bulabula N, Jekins A, Mehtar S, Nathwani D. Education and management of antimicrobials amongst nurses in Africa a situation analysis: An Infection Control Africa Network (ICAN)/BSAC online survey. J. Antimicrob. Chemother. 73(5), 1408–1415 (2018). • Illustrates public health concern associated with ABR and the proliferation of multidrug resistant pathogens as well as the threat that lies ahead.
  Medline CASGoogle Scholar
• 3. Musicha P, Cornick J, Bar-Zeev N et al. Trends in antimicrobial resistance in bloodstream infection isolates at a large urban hospital in Malawi (1998–2016): a surveillance study. Lancet Infect. Dis. 17(10), 1042–1052 (2017).
  MedlineGoogle Scholar
• 4. Gajdács M. The concept of an ideal antibiotic: implications for drug design. Molecules 24, 892 (2019).
  Google Scholar
• 5. Gajdács M, Albericio F. Antibiotic resistance: from the bench to patients. Antibiotics 8, 129 (2019).
  Google Scholar
• 6. Christaki E, Giamarellos-Bourboulis J. The complex pathogenesis of bacteremia: from antimicrobial clearance mechanisms to the genetic background of the host. Virulence 5(1), 57–65 (2014). •• Highlights the factors that influence the rate of community-acquired bacteremia.
  MedlineGoogle Scholar
• 7. Bennett L, Beeson B. Bacteremia: a consideration of some experimental and clinical aspects. Yale J. Biol. Med. 26(4), 241–262 (1954).
  MedlineGoogle Scholar
• 8. Guimaraes O, Cao K, Hong O, Mayba M. A prognostic model of persistent bacteremia and mortality in complictated Staphylococcus aureus bloodstream infection. Clin. Infect. Dis. 68(9), 1502–1511 (2019). •• Shows significance with regards to understanding blood stream infections and their significant global impact on morbidity and mortality in hospitals.
  Medline CASGoogle Scholar
• 9. Ahmed N, Hussain T. Antimicrobial susceptibility patterns of leading bacterial pathogens isolated from laboratory confirmed blood stream infections in a multi-specialty sanatorium. J. Glob. Infect Dis. 6, 141–146 (2014).
  Medline CASGoogle Scholar
• 10. Reddy A, Shaw V, Crump A. Community-acquired bloodstream infections in Africa: a systematic review and meta-analysis. Lancet Infect. Dis. 10(6), 417–432 (2010).
  MedlineGoogle Scholar
• 11. Tambekar D, Dhanorkar D, Gulhane S et al. Bacterial pathogens and their antimicrobial susceptibility in Gaza strip, Palestine. J. Med. Sci. 7, 493–496 (2014). •• Provides indepth insight regarding various methods of detecting bacterial pathogens within patient’s blood, as well as highlights the major cause of bacteremia.
  Google Scholar
• 12. Pourakbari B, Sadr A, Ashtiani M et al. Five-year evaluation of the antimicrobial susceptibility patterns of bacteria causing bloodstream infections in Iran. J. Infect. Dev. Ctries. 6(2), 120–125 (2012).
  MedlineGoogle Scholar
• 13. Ugrakli S, Okumuş E, Doğan M. Identification of bacterial pathogens in blood specimens and antibiotic resistance profiles of Acinetobacter species in a University Hospital, Kenya. J. Clin. Microbiol. Biochem. Technol. 3(1), 004–008 (2017).
  Google Scholar
• 14. Asante K, Boamah E, Abdulai M et al. Knowledge of antibiotic resistance and antibiotic prescription practices among prescribers in the Brong Ahafo Region of Ghana; a cross-sectional study. BMC Health. Serv. Res. 17(1), 422 (2017).
  MedlineGoogle Scholar
• 15. Leopold S, van Leth F, Tarekegn H, Schultsz C. Antimicrobial drug resistance among clinically relevant bacterial isolates in sub-Saharan Africa: a systematic review. J. Antimicrob. Chemother. 69, 2337–2353 (2014).
  Medline CASGoogle Scholar
• 16. Farley E, Stewart A, Davies M, Govind M, van den Bergh D, Boyles T. Antibiotic use and resistance: knowledge, attitudes and perceptions among primary care prescribers in South Africa. S. Afr. Med. J. 108(9), 763–771 (2018).
  Medline CASGoogle Scholar
• 17. Rehman I, Asad M, Bukhsh A et al. Knowledge and practice of pharmacists toward antimicrobial Stewardship in Pakistan. Pharmacy 6, 116 (2018).
  Google Scholar
• 18. Berha A, Amin D, Alebachew M. Awareness and beliefs of antimicrobial resistance among health professionals working at Tikur Anbessa Specialized Hospital, Addis Ababa: Ethiopia. J. Bioanal. Biomed. 9, 123–129 (2017). •• Reveales that despite impressive achievements reached both in the field of microbiological diagnosis and antimicrobial therapy, bacteremia still accounts for a significant percentage of morbidity and mortality.
  Google Scholar
• 19. De Kraker M, Jarlier V, Monem J, Heuer O, Van de Sande N, Grundmann H. The changing epidemiology of bacteraemias in Europe: trends from the European Antimicrobial Resistance Surveillance System. Clin. Microbiol. Infect. 13, 860–868 (2013).
  Google Scholar
• 20. De Kraker E, Stewardson A, Harbarth S. Will 10 million people die a year due to antimicrobial resistance by 2050? PLoS Med. 13(11), e1002184 (2016).
  MedlineGoogle Scholar
• 21. CLSI. Performance Standards for Antimicrobial Susceptibility Testing. (27th Edition) Wayne C (Ed.). Clinical and Laboratory Standards Institute, PA, USA, (2017).
  Google Scholar
• 22. Sader S, Flamm R, Mendes R, Farrell D, Jones R. Antimicrobial activities of ceftaroline and comparator agents against bacterial organisms causing bacteremia in patients with skin and skin structure infections in US medical centers, 2008 to 2014. Antimicrob. Agents Chemother. 60(4), 2558–2563 (2016). •• Provides the state of awareness regarding the use of antimicrobial resistance (AMR), the beliefs of AMR as well as the real threat AMRs imposes to disease management.
  Medline CASGoogle Scholar
• 23. Marando R, Seni J, Mirambo M et al. Predictors of the extended-spectrum-beta lactamases producing Enterobacteriaceae neonatal sepsis at a tertiary hospital, Tanzania. Int. J. Med. Microbiol. 308(7), 803–811 (2018).
  Medline CASGoogle Scholar
• 24. Ghotaslou R, Ghorashi Z, Nahaei M. Klebsiella pneumoniae in neonatal sepsis: a 3-year-study in the pediatric hospital of Tabriz Iran. Jpn J. Infect. Dis. 60(2–3), 126–128 (2007).
  MedlineGoogle Scholar
• 25. Namikawa H, Niki M, Niki M, Yamada K, Nakaie K. Clinical and virulence factors related to the 30-day mortality of Klebsiella pneumoniae bacteremia at a tertiary hospital: a case–control study. Eur. J. Clin. Microbiol. Infect. Dis. 38(12), 2291–2297 (2019). •• Illustrates empirical evidence with regards to the most frequently isolated bacteria from patients with sepsis as well as provided ways through which these organisms evade phagocytosis.
  Medline CASGoogle Scholar
• 26. Moffa M, Guo W, Li T, Cronk R, Abebe L, Bartram J. A systematic review of nosocomial waterborne infections in neonates and mothers. Int. J. Hyg. Environ. Health 220(8), 1199–1206 (2017).
  MedlineGoogle Scholar
• 27. Bengoechea A, Sa Pessoa J. Klebsiella pneumoniae infection biology: living to counteract host defences. FEMS Microbiol. Rev. 43(2), 123–144 (2019).
  Medline CASGoogle Scholar
• 28. Gajdács M, Bátori Z, Ábrók M, Lázár A, Burián K. Characterization of resistance in gram-negative urinary isolates using existing and novel indicators of clinical relevance: a 10-year data analysis. Life 10(2), 16 (2020).
  CASGoogle Scholar
• 29. Iacchini S, Sabbatucci M, Gagliotti C, Rossolini G, Moro M. Bloodstream infections due to carbapenemase-producing Enterobacteriaceae in Italy: results from nationwide surveillance. Euro. Surveill. 24(5), 1800159 (2019).
  Google Scholar
• 30. Chiyangi H, Muma B, Malama S et al. Identification and antimicrobial resistance patterns of bacterial enteropathogens from children aged 0–59 months at the University Teaching Hospital, Lusaka, Zambia: a prospective cross-sectional study. BMC Infect. Dis. 17(1), 117 (2017).
  MedlineGoogle Scholar
• 31. Chishimba K, Hang'ombe B, Muzandu K et al. Detection of extended-spectrum beta-lactamase-producing Escherichia coli in market-ready chickens in Zambia. Int. J. Microbiol. 2016, 1–5 (2016).
  Google Scholar
• 32. Zulu A, Matafwali S, Banda M, Mudenda S. Assessment of knowledge, attitude, and practices on antibiotic resistance among undergraduate medical students in the school of medicine at the University of Zambia. Int. J. Basic Clin. Pharmacol. 9, 263–270 (2020).
  Google Scholar
• 33. Kalungia A, Mwambula H, Munkombwe D et al. Antimicrobial stewardship knowledge and perception among physicians and pharmacists at leading tertiary teaching hospitals in Zambia: implications for future policy and practice. J. Chemother. 31(7–8), 378–387 (2019).
  MedlineGoogle Scholar
• 34. Saleem Z, Saeed H, Ahmad M et al. Antibiotic self-prescribing trends, experiences and attitudes in upper respiratory tract infection among pharmacy and non-pharmacy students: a study from Lahore. PLoS ONE 11(2), e0149929 (2016).
  MedlineGoogle Scholar
• 35. Markovic-Pekovic V, Grubisa N. Self-medication with antibiotics in the Republic of Srpska community pharmacies: pharmacy staff behavior. Pharmacoepidemiol. Drug Saf. 21(10), 1130–1133 (2012).
  MedlineGoogle Scholar
• 36. Franco BE, Altagracia Martínez M, Sánchez Rodríguez MA, Wertheimer AI. The determinants of the antibiotic resistance process. Infect. Drug Resist. 2, 1–11 (2009).
  Medline CASGoogle Scholar
• 37. Folgori L, Bielicki J. Advances in pediatric septic shock: future challenges in pediatric and neonatal sepsis: emerging pathogens and antimicrobial resistance. J. Pediatr. Intensive Care 8(1), 17–24 (2019).
  MedlineGoogle Scholar
• 38. Gajdács M. Epidemiology and antibiotic resistance trends of Pantoea species in a tertiary-care teaching hospital: a 12-year retrospective study. Dev. Health Sci. 2(3), 72–75 (2019).
  Google Scholar
• 39. Kalonga J, Hangoma J, Banda M, Munkombwe D, Mudenda S. Antibiotic Prescribing Patterns in Paediatric Patients at Levy Mwanawasa University Teaching Hospital in Lusaka. Int. J. Pharm. Pharmacol. 4(1), 138 (2020).
  Google Scholar
• 40. Saleem Z, Hassali M, Godman B, Fatima M, Ahmad Z, Sajid A. Sale of WHO AWaRe groups antibiotics without a prescription in Pakistan: a simulated client study. J. Pharm. Policy Pract. 13, 26 (2020).
  MedlineGoogle Scholar
• 41. Sharland M, Pulcini C, Harbarth S et al. Classifying antibiotics in the WHO Essential Medicines List for optimal use – be AWaRe. Lancet Infect. Dis. 18(1), 18–20 (2018).
  MedlineGoogle Scholar
• 42. WHO. WHO Model List of Essential Medicines. (20th Edition). (2017). http://www.who.int/medicines/publications/essentialmedicines/20th_EML2017.pdf?
  Google Scholar
• 43. Budd E, Cramp E, Sharland M et al. Adaptation of the WHO Essential Medicines List for national antibiotic stewardship policy in England: being AWaRe. J. Antimicrob. Chemother. 74(11), 3384–3389 (2019).
  Medline CASGoogle Scholar
• 44. Hsia Y, Lee B, Versporten A, Yang Y, Bielicki J, Jackson C. Use of the WHO Access, Watch, and Reserve classification to define patterns of hospital antibiotic use (AWaRe): an analysis of paediatric survey data from 56 countries. Lancet Glob. Health 7, e861–871 (2019).
  MedlineGoogle Scholar
• 45. Johnson A, Muller-Pebody B, Budd E, Ashiru-Oredope D, Ladenheim D. Improving feedback of surveillance data on antimicrobial consumption, resistance and stewardship in England: putting the data at your Fingertips. J. Antimicrob. Chemother. 72(4), 953–956 (2017).
  Medline CASGoogle Scholar
• 46. Godman B, Haque M, Mckimm J et al. Ongoing strategies to improve the management of upper respiratory tract infections and reduce inappropriate antibiotic use particularly among lower and middle-income countries: findings and implications for the future. Curr. Med. Res. Opin. 36(2), 301–327 (2020).
  MedlineGoogle Scholar
• 47. Mudenda S, Bangara F, Sitali J, Banda M. Knowledge, attitude, and practices on antibiotic resistance among Pharmacists at the University Teaching hospitals in Lusaka, Zambia. J. Harmon. Res. Pharm. 8(2), 12–25 (2019).
  Google Scholar
• 48. Godman B, Fadare J, Kibuule D et al. Initiatives across countries to reduce antibiotic utilisation and resistance patterns: impact and implications. In: Drug Resistance in Bacteria, Fungi, Malaria, and Cancer. Arora GSajid AKalia VC (Eds). Springer, Cham,Switzerland, 539–576 (2017).
  Google Scholar
• 49. Saleem Z, Hassali M, Hashmi F. Pakistan’s national action plan for antimicrobial resistance: translating ideas into reality. Lancet Infect. Dis. 18(10), 1066–1067 (2018).
  MedlineGoogle Scholar
• 50. Gajdács M, Paulik E, Szabó A. Knowledge, attitude and practice of community pharmacists regarding antibiotic use and infectious diseases: a cross-sectional survey in Hungary (KAPPhA-HU). Antibiotics 9(2), 41 (2020).
  Google Scholar
• 51. Gajdács M. Carbapenem-Resistant but cephalosporin-susceptible Pseudomonas aeruginosa in urinary tract infections: opportunity for colistin sparing. Antibiotics 9(4), 153 (2020).
  CASGoogle Scholar